Tag

Organ Transplantation

All articles tagged with #organ transplantation

Wood frog’s freeze-thaw trick guides long‑term organ preservation
science9 hours ago

Wood frog’s freeze-thaw trick guides long‑term organ preservation

A North American wood frog survives winter by freezing 65–70% of its body water and stopping its heart and breathing, then thawing in spring. Researchers are translating this into organ preservation strategies, using frog-inspired steps like controlled ice formation and a glucose-based antifreeze to extend storage windows. Notably, five human livers have been kept viable for 27 hours at -4°C, and pig kidneys were preserved for 10 days in demonstration work, with thawing remaining the key hurdle. The goal is to move organ storage from hours to days by reproducing the frog’s protective sequence in human tissues.

Putin’s Longevity Gamble: $26B, Pigs, and Cryo Chambers
politics2 months ago

Putin’s Longevity Gamble: $26B, Pigs, and Cryo Chambers

Vox analyzes Vladimir Putin’s $26 billion longevity program, detailing plans to replace organs with lab-made tissues and genetically engineered mini pigs, plus the use of cryo chambers, all spearheaded by Putin and his inner circle (including his daughter Maria Vorontsova). The piece frames how Russia’s autocratic system is funding a quest to extend life amid demographic decline and ongoing war, a bold but uncertain pursuit with broad implications for power and public health.

Trial Suggests Liver Transplants Could Free Recipients From Lifelong Immunosuppressants
health4 months ago

Trial Suggests Liver Transplants Could Free Recipients From Lifelong Immunosuppressants

A small University of Pittsburgh study tested donor-derived regulatory dendritic cell therapy to train recipients’ immune systems to accept a transplanted liver. Among 13 living-donor liver recipients, cells were given before transplant and patients remained on standard immunosuppressants for a year; eight were weaned off, with four stopping entirely and three staying drug-free for about three years on average. The trial raised the drug-free success rate to 37.5% from the typical 13–16%, but researchers caution that results are early and require larger, comparative studies to confirm effectiveness and optimize treatment.

Swiss Man Regains Hands After 17 Years with Double Transplant
health1 year ago

Swiss Man Regains Hands After 17 Years with Double Transplant

A Swiss man, Luka Kriszanac, who lost his hands and legs at age 12 due to sepsis, successfully received a double hand transplant at Penn Medicine after a 17-year wait, demonstrating a significant medical breakthrough in vascularized composite allotransplantation and highlighting the lifelong relationship between patients and their medical teams.

Stem Cells in Kidney Transplants May Eliminate Need for Anti-Rejection Drugs
health2 years ago

Stem Cells in Kidney Transplants May Eliminate Need for Anti-Rejection Drugs

A phase 3 clinical trial has shown that adding stem cells from the organ donor to kidney transplants can help patients wean off lifelong anti-rejection drugs, which have harmful side effects. The trial found that 16 out of 19 patients were able to stop taking these drugs after two years. This approach, which involves creating a hybrid immune system through "mixed chimerism," could potentially extend the lifespan of transplanted kidneys and reduce the need for repeat transplants. However, more research is needed to apply this method to a broader range of patients and other types of organ transplants.

"Houston Hospitals Resume Transplant Program Amid Allegations of Database Manipulation"
health2 years ago

"Houston Hospitals Resume Transplant Program Amid Allegations of Database Manipulation"

Houston Methodist Hospital is reviewing nearly 75 patients left without options after Memorial Hermann's transplant programs were shut down amid accusations of a surgeon manipulating donor databases and possibly preventing some patients from receiving livers. The U.S. Department of Health and Human Services is investigating the allegations, and some of Memorial Hermann's patients may be moving to Houston Methodist for care. UTHealth stands behind the surgeon, while investigators oversee the federal investigation to protect patient safety and equitable access to organ transplant services.

"Allegations Against Houston Surgeon Steve Bynon for Manipulating Liver Transplant Records"
healthcare2 years ago

"Allegations Against Houston Surgeon Steve Bynon for Manipulating Liver Transplant Records"

Dr. J. Steve Bynon Jr., a prominent transplant surgeon in Houston, is accused of altering patient records to deny them liver transplants, leading to the suspension of the liver and kidney transplant programs at Memorial Hermann-Texas Medical Center. The hospital is investigating the allegations, and both the U.S. Department of Health and Human Services and the United Network for Organ Sharing are also involved. Patients have been contacted to explore alternative care options, and the severity of the allegations has prompted a thorough response from regulatory authorities and medical professionals.

"Landmark Pig Kidney Transplant Patient Experiences Tense Rejection Episode Before Leaving Hospital"
health2 years ago

"Landmark Pig Kidney Transplant Patient Experiences Tense Rejection Episode Before Leaving Hospital"

The world's first recipient of a genetically modified pig kidney transplant experienced a rejection episode before leaving the hospital, but has since shown no further signs of distress. The groundbreaking procedure, performed by Massachusetts General Hospital, involved a transplant of an engineered porcine kidney, and the positive outcome is an encouraging sign for future trials of cross-species transplantation. The patient's recovery is being closely monitored, and ongoing discussions are being held with the FDA about initiating a clinical trial for pig kidney transplants.

"First Recipient of Genetically-Edited Pig Kidney Transplant Discharged from Hospital"
health2 years ago

"First Recipient of Genetically-Edited Pig Kidney Transplant Discharged from Hospital"

Richard Slayman, 62, has become the first patient to receive a kidney from a genetically modified pig and has been discharged from the hospital just two weeks after the groundbreaking surgery. The successful outcome of the transplant represents a significant moment in medicine and could potentially signal a new era of cross-species organ transplantation. Slayman expressed gratitude for the exceptional care he received and is now looking forward to a healthier future.

"Revolutionizing Organ Transplantation: The Cutting-Edge Technique"
health2 years ago

"Revolutionizing Organ Transplantation: The Cutting-Edge Technique"

The use of perfusion, a technique that keeps donated organs alive outside the body, is reshaping organ transplantation by increasing the number of transplants possible and changing the way surgeons operate. This technology has led to a significant increase in the volume of liver, lung, and heart transplants, with some surgical programs experiencing a 30 percent uptick in transplants since its adoption. Additionally, the field is exploring the use of organs from genetically modified animals as potential sources for transplants.